Teva Pharmaceutical Industries Ltd
Close on Nov 18, 2026Market cap $49.21BP/E 70.4Yield –
Teva Pharmaceutical Industries Anda, Inc. by Quarter
Anda, Inc. — Third-Party Pharmaceutical Distribution Revenues (U.S.) ($M)
Teva Pharmaceutical Industries Anda, Inc.: $401M in Q3 2026, up 2.3% from a year earlier.
Where the Q3 2026 figure comes from
“currency terms, compared to the third quarter of 2025. Anda revenues from third-party products in the third quarter of 2026 were $401 million, an increase of 2%, compared to the third quarter of 2025, mainly due to highe”
Source: Form 8-K Earnings Release (0001171843-26-007054) ↗
Revenues of Anda, Inc. (Teva's U.S. wholesale distributor of generic, brand, specialty, and OTC pharmaceutical products to independent pharmacies, chains, and clinics). Reported within North America / U.S. through FY2025 and moved to Other Activities in Q1 2026.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up anda, Inc.
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Anda, Inc. ($M), quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/sub-anda-rev
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?